KEMPHARM INC
Acción · US4884452065 · ZVRA · A2QLX7 (XNAS)
9,49 USD
13.06.2025 20:19
Cotizaciones actuales de KEMPHARM INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
ZVRA
|
USD
|
13.06.2025 20:19
|
9,49 USD
| 9,37 USD
+1,28 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 3,15 % | 16,58 % | 14,20 % | 11,91 % | 104,09 % | 207,32 % |
Perfil de la empresa para KEMPHARM INC Acción
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia (IH). The company's lead product candidate KP1077 which is under Phase II clinical trial for the treatment of IH and narcolepsy, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. It is also developing KP879, a prodrug product candidate for the treatment of stimulant use disorder and is under Phase I clinical trial. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. KemPharm, Inc. has collaboration and license agreement, with KVK-Tech, Inc. and Commave Therapeutics SA. The company was incorporated in 2006 and is headquartered in Celebration, Florida.
Datos de la empresa
Nombre KEMPHARM INC
Empresa KemPharm, Inc.
Símbolo ZVRA
Sitio web
https://kempharm.com
Mercado principal
NASDAQ

WKN A2QLX7
ISIN US4884452065
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Richard W. Pascoe
Capitalización de mercado 200 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,0 T
Dirección 1180 Celebration Boulevard, 34747 Celebration
Fecha de OPV 2015-04-16
Splits de acciones
Fecha | Split |
---|---|
28.12.2020 | 1:16 |
Cambios de identificador
Fecha | De | A |
---|---|---|
01.03.2023 | KMPH | ZVRA |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | 1GDA.F |
NASDAQ | KMPH |
NASDAQ | ZVRA |
Otras acciones
Los inversores que tienen KEMPHARM INC también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.